Accreditation Information

CME

The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Medical knowledge

Other

UK Healthcare CECentral certifies this activity for 6.25 hours of participation.

Objectives

Upon completion of this activity, participants will be able to:
1. Identify lymphoma subtypes for better patient selection
2. Review the role of individual treatment options and their combinations, when to use them
3. Review of risk stratification and identification of molecular targets in acute leukemia and MDS, with focus on initial work up and subsequent treatment options
4. Review of targeted use of kinase inhibitors in these diseases and review of indication for transplant and its outcome
5. Discuss the Update on management of hemophilia and clotting disorders
6. Review advances in drug selections for CLL, discuss their efficacy and their toxicity
7. Discuss an updated overview on transplant indications in the elderly, on the use of mismatched donors (with now very good outcomes) and emphasize the need for early transfer to BMT center.
8. Review novel approaches of immunotherapy, which constantly do expand and mature.

Target Audience

Hematologists, APRNs, PAs, clinical researchers, clinical residents and anyone interested in Hematology & Immunotherapy.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by the University of Kentucky are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.